amediplase

Known as: K2tu-PA 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2012
012320022012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
  • BioDrugs
  • 2012
 
  • table II
Is this relevant?
2006
2004
2004
Amediplase (K(2) tu-PA) is a hybrid plasminogen activator, consisting of the kringle 2 domain of alteplase and the protease… (More)
Is this relevant?
Review
2004
Review
2004
Amediplase, a chimeric protein containing functional domains of both tissue plasminogen activator and pro-urokinase plasminogen… (More)
Is this relevant?
2004
2004
420 Thrombin-activatable fibrinolysis inhibitor (TAFI) is a 60kDa metallocarboxypeptidase produced by the liver and present in… (More)
Is this relevant?
2002
2002
  • BioDrugs : clinical immunotherapeutics…
  • 2002
Amediplase [CGP 42935, MEN 9036, K2tu-PA] is a recombinant chimeric plasminogen activator, consisting of the kringle 2 domain… (More)
Is this relevant?